Anticoagulant, Fibrinolytic and Antiaggregant Activity of Carrageenans and Alginic Acid

Botanica Marina

Volumn 34, Issue 5, 1991, Pages 429-432

  Giiven, K C ^a   Ozsoy, Y ^a   Ulutin, O N ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961486587     PISSN: 00068055     EISSN: 14374323     Source Type: Journal    
DOI: 10.1515/botm.1991.34.5.429     Document Type: Article

References (31)

1. Adams, S. S. and H. M. Thorpe. 1957. The anticoagulant activity and toxicity of laminarin sulphate K. J. Pharm. Pharmacol. 9: 459 — 463.
2. Anderson, W. and J. G. C. Duncan. 1965. The anticoagulant activity of carrageenan. J. Pharm. Pharmacol. 17: 647 — 654.
3. Astrup, T. and S. Müllertz. 1952. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. Biophys. 40: 346–351.
4. Born, G. V. R. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927—929.
5. Constantinides, P. A. Cairns and A. Werner. 1954. Antilipemic activity of sulfated polysaccharides. Arch. Int. Pharmacodyn. 99: 334–345.
6. Deacon-Smith, R. A., J. P. Lee-Potter and D. J. Rogers. 1985 a. Anticoagulant activity in extracts of British marine algae. Bot. Mar. 28: 333–338.
7. Deacon-Smith, R. A., J. P. Lee-Potter and D. J. Rogers. 1985 b. Platelet aggregation in the presence of extracts of British marine algae. Med. Lab. Sci. 42: 404—405.
8. Elsner H., W. Broser and E. Biirgel. 1937, Über das Vorkommen von hochwirksamen, die Blutgerinnung hemmenden Stoffen in Rotalgen. Z. Physiol. Chem. 246: 244 — 247.
9. Elsner H. 1938. Über das Vorkommen von hochwirksamen, die Blutgerinnung hemmenden Stoffen in Meeresalgen. II. Z. Physiol. Chem. 252: 196–200.
10. Güven, K. C., E. Güler, E. Aktin and H. Koyuncuoglu. 1979. Studies on Pterocladia capillacea (Gmel.) Born et Thur. Part II. In (H. A. Hoppe, T. Levring and Y. Tanaka, eds) Marine Algae in Pharmaceutical Science. Walter de Gruyter, Berlin, New York. pp. 693–710.
11. Giiven, K. C. and B. Giivener. 1985 a. Metachromatic. identification of (iota-kappa-lambda) carrageenans. Bot. Mar. 28: 221–222.
12. Giiven, K. C. and B. Güvener. 1985 b. A metachromatic method for the identification of alginic acid, agar and carrageenan. Fette, Seifen, Anstrichmittel 87: 172—176.
13. Giiven, K. C., B. Giivener and E. Giiler. 1990. Pharmacological activities of marine algae. In (I. Akatsuka, ed.) Introduction to Applied Phycology. SPB Academic Publishing, The Hague, The Netherlands, pp. 67—92.
14. Giiven, K. C., B. Güvener and N. Giiven. 1984. Succinic acid and Carrageenan from Acanthophora delilei Lamouroux and Grateloupia dichotoma J. Agardh. Acta Pharm. Turc. 26: 49–52.
15. Giiven, K. C., §. B. Ulutin, E. Mutluay and O. N. Ulutin. 1973/74. Anticoagulant-antithrombin and fibrinolytic actions of extract of marine algae Corallina rubens L. Haemostasis 2: 260—268.
16. Hawkins, W. W. and A. N. O'Neill. 1955. The anticoagulant action in blood of sulphated derivatives of laminarin. Can. J. Biochem. Physiol. 33: 545 — 552.
17. Hawkins, W. W. and V. G. Leonard. 1962. Antipeptic and antithrombic properties of carrageenin. J. Lab. Clin. Med. 60: 641–648.
18. Hawkins, W. W. and V. G. Leonard. 1963. The antithrombic activity of carrageenin in human blood. Can. J. Biochem. Physiol. 41: 1325–1327.
19. Houck, J. C., R. K. Morris and E. J. Lazaro. 1957. Anticoagulant, lipemia clearing and other effects of anionic polysaccharides extracted from seaweed. Proc. Soc. Exp. Biol. Med. 96: 528–530.
20. Kindness, G., W. F. Long and F. B. Williamson. 1979 a. Enhancement of antithrombin III activity by carrageenans. Thrombosis Research 15: 49—60.
21. Kindness, G., W. F. Long, F. B. Williamson and J. Boyd. 1979 b. Effects of carrageenans on the aggregation of human blood platelets. Thrombosis Research 15: 3 — 15.
22. Kindness, G., F. B. Williamson and W. F. Long. 1980. Inhibition by antithrombin III of carrageenan- and xylan SP54-induced aggregation of human blood platelets. Biochem. Soc. Trans. 8: 84—85.
23. Margolis, J. 1967. Initiation of blood coagulation by glass and related surfaces. J. Physiol. 137: 95—109.
24. McMilan, R. M., D. E. McIntyre and J. L. Gordon. 1979. Stimulation of human platelets by carrageenans. J. Pharm. Pharmacol. 31: 148 — 152.
25. Nordey, H., P. Amesen and H. C. Godal. 1980. The euglobin lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venos stanis. Scand. J. Haemat. 25: 401–406.
26. Pitney, W. R. and J. V. Dacie. 1953. A simple method of studying the generation of thrombin in recalcified plasma. J. Clin. Path. 6: 9–13.
27. Quick, A. J. 1945. On the quantitative estimation of prothrombin. Amer. J. Clin. Path. 15: 560—566.
28. Schimpf, Kl., J. Lenhard and G. Schaaf. 1969. The influence of the polysaccharide carrageenin on the clotting mechanism of the blood in the rabbit in vitro and in vivo. Thromb. Diath. Haemorrh. 24: 524—533.
29. Schwartz, H. J. and R. W. Kellermeyer. 1969. Carrageenan and delayed hypersensitivity II. Activation of Hageman factor by carrageenan and its possible significance. Proc. Soc. Exp. Biol. Med. 132: 1021 -1024.
30. Springer, G. F., H. A. Würzel, G. M. McNeal, Jr., N. J. Ansell and M. F. Doughty. 1957. Isolation of anticoagulant fractions from crude fucoidin. Proc. Soc. Exp. Biol. Med. 94: 404–409.
31. Vargaftig, B. B. 1977. Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors. J. Pharm. Pharmacol. 29: 222 — 228.